Sino Biological announces the construction of a new bioprocessing center in the United States

Sino Biological, Inc. (“Sino Biological” or the “Company”), a biotechnology company listed on the Shenzhen Stock Exchange ChiNext (SZSE: 301047), a provider of biological research reagents and related technical contract research services, is pleased to announce the formal signing of a lease agreement with Hines and the commencement of construction of a new Center for Bioprocessing (C4B) at its Levit Green facility in Houston, Texas, USA.

Image credit: Sino Biological

Headquartered in Beijing, China with subsidiaries in Suzhou, China; Taizhou, China; Frankfurt, Germany; Kawasaki, Japan; and Wayne, Pennsylvania and listed on the Shenzhen Stock Exchange ChiNext (SZSE: 301047), Sino Biological is a world leader in recombinant proteins, antibodies and related contract research services from mammalian cells. This new site serves as the company’s first manufacturing facility in the United States. Named the Center for Bioprocessing (C4B), the facility will focus on both product manufacturing and performing contract research services. Levit Green will further establish its presence in Houston, providing businesses, academics and medical researchers at the world-renowned Texas Medical Center and the region with invaluable access to Sino Biological’s comprehensive offering of biologic reagents and CRO services.

We are extremely excited about our new partnership with the Hines team and our upcoming labs and manufacturing facility at Levit Green. Hines is at the forefront of the design and development of next-generation laboratory space, and our new location in the Levit Green master-planned district in the heart of the Texas Medical Center in Houston will enable Sino Biological to significantly expand its research services and bioreagent manufacturing capabilities in the United States.”

Dr. Rob Burgess, Chief Commercial Officer, Sino Biological

“I am pleased with the development of the Center for Bioprocessing in Houston. I strongly believe in excellent science and the latest technology, which is why I joined Sino Biological. I have assembled a world-class team that is now establishing C4B with the ultimate goal of advancing the scientific development of next-generation precision medicine therapeutic antibodies and proteins,” said Dr. Yingmin Zhu, head of C4B.

“Levit Green was carefully designed to provide best-in-class life science space that accommodates multiple uses. “Welcoming Sino Biological is a testament to the market’s need for an advanced, flexible space that enables diverse companies to conduct a variety of research,” said John Mooz, Chief Executive Officer of Hines. “Sino Biological is a great addition to the province’s growing life sciences ecosystem, and we look forward to supporting their continued growth and success.”

Leave a Comment

Your email address will not be published. Required fields are marked *